search
Back to results

ADT Exercise Trial and Economic Analysis (ADTExRCT)

Primary Purpose

Prostate Cancer

Status
Completed
Phase
Phase 3
Locations
Canada
Study Type
Interventional
Intervention
Supervised Group Exercise
Home Based Exercise
Sponsored by
University Health Network, Toronto
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Prostate Cancer

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • men with histologically confirmed PC who are starting or continuing on ADT for at least 6 months or who are in an androgen-deprived (or castrate) state for the duration of the intervention
  • fluent in English
  • able to provide consent
  • close to a study centre

Exclusion Criteria:

  • already meeting guidelines for moderate to vigorous physical activity (MVPA) - conditions that would interfere with ability to participate

Sites / Locations

  • University of Calgary/Tom Baker Cancer Centre
  • Southlake Regional Health Centre
  • Scarborough and Rouge Hospital
  • Princess Margaret Cancer Centre

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Group-Supervised

Home-Based

Arm Description

This intervention arm will include 3 group, supervised sessions per week for 6 months with a certified exercise specialist. Supervised sessions will be delivered in a group format with 4-8 participants per group. Flexibility training will include stretching for 5-10 minutes at the beginning and end of each session. Aerobic training will involve 30 minutes of low-impact step aerobics. Resistance training will be conducted using resistance bands, a stability ball, and an exercise mat with 8 prescribed exercises that target the major muscle groups. Participants will be encouraged to perform exercises independently on additional days, for a total of 4-5 days per week of exercise.

The same protocol and training frequency as the supervised programs described above will be followed. However, all exercises will be completed independently by participants. Specific exercises in the aerobic program may be modified to accommodate patient preference (same target heart rate range as the supervised group). Participants will be supported with smartphone technology and remote 'health coaches' during the intervention phase. This will help to ensure participant adherence, appropriate progression, and safety.

Outcomes

Primary Outcome Measures

Functional Assessment of Cancer Therapy-Fatigue (FACT-F)
The FACT-F is a questionnaire that includes 13 items measuring cancer-related fatigue.
6 Minute Walk Test (6MWT)
The 6MWT is a commonly used, validated measure that assesses functional endurance.

Secondary Outcome Measures

Functional Assessment of Cancer Therapy-General (FACT-G)
The FACT-G is a questionnaire that is well-validated and widely used to measure quality of life (QOL).
Functional Assessment of Cancer Therapy-Prostate (FACT-P)
The FACT-P is a questionnaire that supplements the FACT-G with 12 prostate-specific items covering domains of urinary function, sexual function, pain, and related symptoms.
5 Times Sit to Stand Test
A common, simple, and validated measure of functional lower body strength.
Grip Strength
Grip strength is a measure of upper body strength and predicts long-term disability and mortality in middle-aged and older adults.
Bioelectrical Impedance Analysis
Body composition will be measured using bioelectrical impedance analysis (BIA).
Waist Circumference and Hip Ratio
Body composition will be measured using waist circumference(WC) and WC:hip ratio, following the standardized Canadian Society for Exercise Physiology - Physical Activity Training for Health (CSEP-PATH) protocol.
Body Mass Index
Body composition will be measured using body mass index (BMI).
Bone Mineral Density (BMD)
Bone mineral density will be measured at lumbar spine, hip, and distal 1/3 radius using dual x-ray absorptiometry (DXA).
Biological Outcomes (blood work)
Fasting lipids, blood glucose, glycated hemoglobin, hemoglobin, prostate-specific antigen (PSA), and testosterone will be measured. Serum banking will also be done for use in future studies.
Sedentary Behaviour
Time spent in activities that are characterized by an energy expenditure ≤ 1.5 metabolic equivalents and a sitting or reclining posture (sedentary behavior) will be assessed using the Sedentary Behaviour Questionnaire that is used in large cohort studies and has demonstrated evidence of reliability and validity.
Planning, Attitudes, & Barriers scale
The Planning, Attitudes, & Barriers scale is a validated questionnaire that will be used to assess likelihood of exercise behavior over time.
Behavioral Regulations in Exercise Questionnaire-2 (BREQ-2)
Behavioral Regulations in Exercise Questionnaire-2 (BREQ-2) is a validated questionnaire that assess predictors of adherence.
Psychological Need Support and Frustration Scale - Relatedness Items
Relatedness will be assessed using the Psychological Need Support and Frustration Scale - Relatedness Items.
Health Care Climate Questionnaire (HCCQ)
The Health Care Climate Questionnaire (HCCQ short form) assess participant perceptions of their health care team.
Walkability
Participant postal codes will be collected to assess neighbourhood walkability (i.e., access to a grocery store within walking distance).
Disease-related Costs
The investigators will collect economically relevant data about health status using preference-based (utility) instruments (European Quality of Life Five Dimensions Questionnaire, EQ-5D). Productivity losses and out-of-pocket expenditures, in addition to hospitalization, drug co-pay, and health visit data will be gathered using a patient questionnaire.
Exercise Adherence
Both accelerometry and the Godin Leisure Time Exercise Questionnaire will be used as a measure of adherence at each time point. Both measures will provide a validated measure of physical activity.

Full Information

First Posted
June 2, 2016
Last Updated
April 11, 2021
Sponsor
University Health Network, Toronto
Collaborators
Tom Baker Cancer Centre, Southlake Regional Health Centre, Scarborough Rouge Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02834416
Brief Title
ADT Exercise Trial and Economic Analysis
Acronym
ADTExRCT
Official Title
A Randomized Control Trial (RCT) and Economic Analysis of Two Exercise Delivery Methods in Men With Prostate Cancer on ADT
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
August 2016 (undefined)
Primary Completion Date
March 31, 2020 (Actual)
Study Completion Date
March 31, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Health Network, Toronto
Collaborators
Tom Baker Cancer Centre, Southlake Regional Health Centre, Scarborough Rouge Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Prostate Cancer (PC) affects 1 in 7 men. Nearly half of those diagnosed with PC will receive androgen deprivation therapy (ADT) as part of their treatment. ADT is good at managing PC but has many side effects. Researchers have shown that exercise, specifically one-on-one supervised exercise improves many of the side effects of ADT. However, exercise programs for men on ADT are not widely available. More questions need to be answered in order for exercise programs to become part of PC treatment. First, can programs that require fewer resources, such as group-exercise or home-based exercise, also improve ADT side-effects? Second, do exercise-related benefits continue beyond the structured exercise program? And what makes people continue exercising? Third, which exercise program is most cost-effective? In this study, the investigators will compare: (a) group supervised in-centre and (b) home-based supported exercise programs to see which program is most effective for men with PC on ADT. The investigators will also look at what motivates people to continue to exercise both during a structured program and after the program is complete and will examine which exercise program is most cost-effective. Participants (men with PC on ADT) will be recruited from one of the following cancer centres: Princess Margaret Cancer Centre in Toronto, the Tom Baker Cancer Centre in Calgary, the Southlake Regional Health Centre in Newmarket, and Scarborough and Rouge Hospital - Centenary Site in Scarborough. When a patient agrees to participate, patient will be randomly placed in 1 of 2 exercise programs. All programs will include the same type of exercises (aerobic, resistance and flexibility) and all participants will exercise 4-5 days per week for 30 minutes per day (as tolerated) for the length of the program (6 months). The investigators will look at how men with PC on ADT respond to the exercise program by measuring quality of life (QOL), fatigue and different physical measures before, during, and after the exercise program. Although the investigators know that supervised one-on-one exercise is most effective at improving ADT side-effects, it is unknown if other forms of exercise are just as beneficial and more financially responsible. This study will allow the investigators to begin to answer these questions so that structured exercise programs become a regular part of PC treatment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prostate Cancer

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Model Description
An a priori decision was made to not include additional covariates in the ANCOVA model due to a smaller than anticipated sample size. Only trial centre, length of ADT, and baseline 6MWT will be included in the model. In addition, we have modified the wear time criteria for accelerometry from 600 minutes of wear time to 500 minutes of wear time. This allows for the inclusion of more participant data and more accurately reflects the clinical nature of this population. Amendment date: 17-Sep-20
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
38 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group-Supervised
Arm Type
Experimental
Arm Description
This intervention arm will include 3 group, supervised sessions per week for 6 months with a certified exercise specialist. Supervised sessions will be delivered in a group format with 4-8 participants per group. Flexibility training will include stretching for 5-10 minutes at the beginning and end of each session. Aerobic training will involve 30 minutes of low-impact step aerobics. Resistance training will be conducted using resistance bands, a stability ball, and an exercise mat with 8 prescribed exercises that target the major muscle groups. Participants will be encouraged to perform exercises independently on additional days, for a total of 4-5 days per week of exercise.
Arm Title
Home-Based
Arm Type
Experimental
Arm Description
The same protocol and training frequency as the supervised programs described above will be followed. However, all exercises will be completed independently by participants. Specific exercises in the aerobic program may be modified to accommodate patient preference (same target heart rate range as the supervised group). Participants will be supported with smartphone technology and remote 'health coaches' during the intervention phase. This will help to ensure participant adherence, appropriate progression, and safety.
Intervention Type
Behavioral
Intervention Name(s)
Supervised Group Exercise
Intervention Description
The exercise program will be delivered in a group format (4-8 participants per group) by a certified exercise specialist.
Intervention Type
Behavioral
Intervention Name(s)
Home Based Exercise
Intervention Description
The exercise program will be executed independently by participants in a home-based setting. Home-based participants will be supported with remote health coaching and smartphone technology.
Primary Outcome Measure Information:
Title
Functional Assessment of Cancer Therapy-Fatigue (FACT-F)
Description
The FACT-F is a questionnaire that includes 13 items measuring cancer-related fatigue.
Time Frame
Every 3 Months for 12 Months
Title
6 Minute Walk Test (6MWT)
Description
The 6MWT is a commonly used, validated measure that assesses functional endurance.
Time Frame
Every 3 Months for 12 Months
Secondary Outcome Measure Information:
Title
Functional Assessment of Cancer Therapy-General (FACT-G)
Description
The FACT-G is a questionnaire that is well-validated and widely used to measure quality of life (QOL).
Time Frame
Every 3 Months for 12 Months
Title
Functional Assessment of Cancer Therapy-Prostate (FACT-P)
Description
The FACT-P is a questionnaire that supplements the FACT-G with 12 prostate-specific items covering domains of urinary function, sexual function, pain, and related symptoms.
Time Frame
Every 3 Months for 12 Months
Title
5 Times Sit to Stand Test
Description
A common, simple, and validated measure of functional lower body strength.
Time Frame
Every 3 Months for 12 Months
Title
Grip Strength
Description
Grip strength is a measure of upper body strength and predicts long-term disability and mortality in middle-aged and older adults.
Time Frame
Every 3 Months for 12 Months
Title
Bioelectrical Impedance Analysis
Description
Body composition will be measured using bioelectrical impedance analysis (BIA).
Time Frame
Every 6 Months for 12 Months
Title
Waist Circumference and Hip Ratio
Description
Body composition will be measured using waist circumference(WC) and WC:hip ratio, following the standardized Canadian Society for Exercise Physiology - Physical Activity Training for Health (CSEP-PATH) protocol.
Time Frame
Every 6 Months for 12 Months
Title
Body Mass Index
Description
Body composition will be measured using body mass index (BMI).
Time Frame
Every 6 Months for 12 Months
Title
Bone Mineral Density (BMD)
Description
Bone mineral density will be measured at lumbar spine, hip, and distal 1/3 radius using dual x-ray absorptiometry (DXA).
Time Frame
Every 6 Months for 12 Months
Title
Biological Outcomes (blood work)
Description
Fasting lipids, blood glucose, glycated hemoglobin, hemoglobin, prostate-specific antigen (PSA), and testosterone will be measured. Serum banking will also be done for use in future studies.
Time Frame
Every 6 Months for 12 Months
Title
Sedentary Behaviour
Description
Time spent in activities that are characterized by an energy expenditure ≤ 1.5 metabolic equivalents and a sitting or reclining posture (sedentary behavior) will be assessed using the Sedentary Behaviour Questionnaire that is used in large cohort studies and has demonstrated evidence of reliability and validity.
Time Frame
Every 6 Months for 12 Months (unless otherwise specified)
Title
Planning, Attitudes, & Barriers scale
Description
The Planning, Attitudes, & Barriers scale is a validated questionnaire that will be used to assess likelihood of exercise behavior over time.
Time Frame
Every 6 Months for 12 Months (unless otherwise specified)
Title
Behavioral Regulations in Exercise Questionnaire-2 (BREQ-2)
Description
Behavioral Regulations in Exercise Questionnaire-2 (BREQ-2) is a validated questionnaire that assess predictors of adherence.
Time Frame
Every 6 Months for 12 Months (unless otherwise specified)
Title
Psychological Need Support and Frustration Scale - Relatedness Items
Description
Relatedness will be assessed using the Psychological Need Support and Frustration Scale - Relatedness Items.
Time Frame
Every 6 Months for 12 Months (unless otherwise specified)
Title
Health Care Climate Questionnaire (HCCQ)
Description
The Health Care Climate Questionnaire (HCCQ short form) assess participant perceptions of their health care team.
Time Frame
Baseline only
Title
Walkability
Description
Participant postal codes will be collected to assess neighbourhood walkability (i.e., access to a grocery store within walking distance).
Time Frame
Baseline only
Title
Disease-related Costs
Description
The investigators will collect economically relevant data about health status using preference-based (utility) instruments (European Quality of Life Five Dimensions Questionnaire, EQ-5D). Productivity losses and out-of-pocket expenditures, in addition to hospitalization, drug co-pay, and health visit data will be gathered using a patient questionnaire.
Time Frame
Every 3 Months for 12 Months
Title
Exercise Adherence
Description
Both accelerometry and the Godin Leisure Time Exercise Questionnaire will be used as a measure of adherence at each time point. Both measures will provide a validated measure of physical activity.
Time Frame
Every 3 Months for 12 Months

10. Eligibility

Sex
Male
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: men with histologically confirmed PC who are starting or continuing on ADT for at least 6 months or who are in an androgen-deprived (or castrate) state for the duration of the intervention fluent in English able to provide consent close to a study centre Exclusion Criteria: already meeting guidelines for moderate to vigorous physical activity (MVPA) - conditions that would interfere with ability to participate
Facility Information:
Facility Name
University of Calgary/Tom Baker Cancer Centre
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T2N 1N4
Country
Canada
Facility Name
Southlake Regional Health Centre
City
Newmarket
State/Province
Ontario
Country
Canada
Facility Name
Scarborough and Rouge Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M1P 2T7
Country
Canada
Facility Name
Princess Margaret Cancer Centre
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G2C4
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
30352568
Citation
Alibhai SMH, Ritvo P, Santa Mina D, Sabiston C, Krahn M, Tomlinson G, Matthew A, Lukka H, Warde P, Durbano S, O'Neill M, Culos-Reed SN. Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT. BMC Cancer. 2018 Oct 23;18(1):1031. doi: 10.1186/s12885-018-4937-x.
Results Reference
derived

Learn more about this trial

ADT Exercise Trial and Economic Analysis

We'll reach out to this number within 24 hrs